Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically modified mouse models for pharmacogenomic research.

Stephen B Liggett1

  • 1University of Cincinnati College of Medicine, 231 Albert Sabin Way, Room G062, Cincinnati, Ohio 45267-0564, USA. stephen.liggett@uc.edu

Nature Reviews. Genetics
|September 17, 2004
PubMed
Summary

Genetic variations in drug-action genes cause differing drug responses. Pharmacogenomics enables personalized medicine, moving beyond a

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic Pathway Selectivity of TAS2R5 toward or Away from β-Arrestin or G Protein from Biased Agonists.

Biochemistry·2026
Same author

Accelerating GPCR drug discovery through computation and experiment integrated with direct detection of ligand binding events.

npj drug discovery·2026
Same author

β<sub>1</sub>- and β<sub>2</sub>-adrenergic Receptor Haplotypes Regulate Therapeutic Responses to Placebo and the Biased Ligand β-blocker Bucindolol.

medRxiv : the preprint server for health sciences·2025
Same author

TAS2R5 screening reveals biased agonism that fails to evoke internalization and downregulation resulting in attenuated desensitization.

PloS one·2025
Same author

Agonist activation to open the Gα subunit of the GPCR-G protein precoupled complex defines functional agonist activation of TAS2R5.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Label-free, real-time monitoring of membrane binding events at zeptomolar concentrations using frequency-locked optical microresonators.

Nature communications·2024

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Drug Discovery

Background:

  • Individual responses to therapeutic drugs vary due to genetic differences in drug-action genes.
  • These variations influence drug effectiveness and can cause adverse reactions.

Purpose of the Study:

  • To explore how pharmacogenomics can shift drug discovery and patient management from a universal approach to genome-tailored therapy.
  • To highlight the role of genetically modified animal models in advancing personalized medicine.

Main Methods:

  • Review of existing evidence on genetic variations and drug response.
  • Discussion of the potential of pharmacogenomics in drug development.
  • Emphasis on the utility of genetically modified mice as models for human drug response variability.

Main Results:

  • Genetic differences significantly impact how individuals respond to drugs.
  • Pharmacogenomics offers a pathway to personalized drug therapy.
  • Genetically modified mice effectively model human genetic variations in drug response.

Conclusions:

  • Pharmacogenomics is crucial for developing personalized medicine.
  • Genetically modified mice are valuable tools for studying interindividual differences in drug response.
  • Tailoring drug therapy to individual genomes promises improved patient outcomes.

Related Experiment Videos